Human Vaccines & Immunotherapeutics: News

Mostrar otras versiones (9)

Oncolytic vaccinia virus vaccine: Promising in liver cancer patients FDA panel endorses quadrivalent influenza vaccines Approval for the first meningitis B vaccine Stallergenes seeks FDA approval for sublingual grass-pollen allergy tablet Live-attenuated dengue vaccine promising in Phase 1 GAVI fund...

Descripción completa

Detalles Bibliográficos
Autor principal: Riedmann, Eva M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
News, Policy & Profiles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903886/
http://dx.doi.org/10.4161/hv.24623
_version_ 1782301164975423488
author Riedmann, Eva M.
author_facet Riedmann, Eva M.
author_sort Riedmann, Eva M.
collection PubMed
description Oncolytic vaccinia virus vaccine: Promising in liver cancer patients FDA panel endorses quadrivalent influenza vaccines Approval for the first meningitis B vaccine Stallergenes seeks FDA approval for sublingual grass-pollen allergy tablet Live-attenuated dengue vaccine promising in Phase 1 GAVI funds HPV vaccines for girls in developing countries First human trials for new superantigen bioterrorism vaccine Hexyon hexavalent pediatric vaccine recommended for approval
format Online
Article
Text
id pubmed-3903886
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-39038862014-03-10 Human Vaccines & Immunotherapeutics: News Riedmann, Eva M. Hum Vaccin Immunother News, Policy & Profiles Oncolytic vaccinia virus vaccine: Promising in liver cancer patients FDA panel endorses quadrivalent influenza vaccines Approval for the first meningitis B vaccine Stallergenes seeks FDA approval for sublingual grass-pollen allergy tablet Live-attenuated dengue vaccine promising in Phase 1 GAVI funds HPV vaccines for girls in developing countries First human trials for new superantigen bioterrorism vaccine Hexyon hexavalent pediatric vaccine recommended for approval Landes Bioscience 2013-04-01 2013-04-01 /pmc/articles/PMC3903886/ http://dx.doi.org/10.4161/hv.24623 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle News, Policy & Profiles
Riedmann, Eva M.
Human Vaccines & Immunotherapeutics: News
title Human Vaccines & Immunotherapeutics: News
title_full Human Vaccines & Immunotherapeutics: News
title_fullStr Human Vaccines & Immunotherapeutics: News
title_full_unstemmed Human Vaccines & Immunotherapeutics: News
title_short Human Vaccines & Immunotherapeutics: News
title_sort human vaccines & immunotherapeutics: news
topic News, Policy & Profiles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903886/
http://dx.doi.org/10.4161/hv.24623
work_keys_str_mv AT riedmannevam humanvaccinesimmunotherapeuticsnews

Ejemplares similares